- Associated Press - Wednesday, August 16, 2017

VIENNA (AP) - Austrian authorities have ordered a recall of a cancer medication that was put on the market without proper approval.

Melphalan is a commonly injected in a solution to treat certain bone marrow cancers. But government medical authorities said Wednesday that “Melphalan Koanaa” - which comes from India - was packaged in Austria by a local company and marketed without official approval.

Austria’s food and drug agency said Wednesday that initial results from analyzing the medication suggest it is safe. It and the Health Ministry say they have filed a criminal complaint against the Austrian company.

Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times is switching its third-party commenting system from Disqus to Spot.IM. You will need to either create an account with Spot.im or if you wish to use your Disqus account look under the Conversation for the link "Have a Disqus Account?". Please read our Comment Policy before commenting.

 

Click to Read More and View Comments

Click to Hide